Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, Masood Shammas, Amer Mahmood, Sulman Basit, Sarah AlMukhaylid, & Zafar Iqbal. (2022). CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML. Journal of Population Therapeutics and Clinical Pharmacology, 29(02), 311–320. https://doi.org/10.53555/jptcp.v29i02.4161